Latest Philippines News

ReNerve’s October AGM presentation points to sharply higher sales, a growing US distribution network and a broader nerve repair pipeline. The company is also progressing a 240-patient NervAlign clinical study while relying on a $5 million RiverFort funding facility to support expansion.

Blackstone Minerals has reported a larger FY2026 loss and warned of material uncertainty around its ability to continue as a going concern, despite ending the year with $13.7 million in cash. The company is directing its remaining financial capacity towards the Mankayan copper-gold project while seeking to reduce exposure to its Vietnam nickel assets.

Celsius Resources has reported a sharply wider FY2026 loss after impairing its disputed interest in the MCB copper-gold project, while an Equinaire credit bid has complicated ownership of the Philippine asset. The company is relying on a pending Opuwo sale, fresh financing and arbitration to keep its development strategy alive.

Tribune Resources delivered a sharply stronger FY2026 result, with revenue up 28.4% and profit attributable to shareholders rising to $75.7 million. The result was helped by a $35.0 million reversal of the prior Raleigh impairment, while operating cash flow and year-end cash both fell.

SportsHero’s FY2026 revenue rose above A$1 million as HeroPlay gained traction through Southeast Asian telco partnerships. But the company remains deeply loss-making, burned A$1.9 million in operating cash and carries a material uncertainty over its ability to continue as a going concern.

OpenLearning has signed a five-year LMS agreement worth a minimum A$1.75 million with one of the Philippines’ largest private education institutions. The contract does not begin until July 2027, but marks the company’s biggest LMS SaaS win in the country.

Tetragon Energy has reported a $470,635 comprehensive loss in its first annual report, while highlighting a Philippine exploration portfolio carrying 3.214 Tcf of net mid-case prospective gas resources. The newly listed explorer ended the period with $715,713 in cash, before raising $4 million through its July ASX listing.

VRX Silica has assembled much of the commercial and regulatory case for Arrowsmith North, including 960,000 tonnes per annum of binding offtakes and a reported A$179.2 million project NPV. The harder test now is funding construction while final approvals, logistics contracts and a final investment decision remain outstanding.

Frontier Digital Ventures has shrunk its top line by 27% as it exits low-margin businesses, but the reset delivered higher EBITDA, a 17% margin and near-total free cash flow conversion in the first half of FY2026. The next test is whether pricing and cost discipline can lift earnings without further customer erosion.

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Peppermint Innovation has shifted from building its Philippines payments platform to commercialising it, but the FY26 report shows the business remains loss-making, balance-sheet constrained and dependent on future funding. The company reported A$217,720 in revenue, a A$2.40 million net loss and negative net assets of A$578,233.